Sero-epidemiology of Priority Arboviruses in French Guiana (EPI-ARBO)

Pasteur Institute

Status: Completed

Conditions: Arbovirus Infections

Treatments: Other: Human Biological samples

Study type: Interventional

Funder types: Industry

Identifiers

NCT03210363

2016-073

Details and patient eligibility

About

Dengue is an important public health problem despite the efforts of local health authorities to mitigate the impact of epidemics and the epidemiology of dengue evolved from an endemo-epidemic to a hyper-endemic state. In late 2013, the first local transmission of chikungunya virus in the Americas was identified in Caribbean countries and territories including French Guiana. Rapidly, more than 16,000 suspected local Health authorities had reported cases. In May 2015, the Pan American Health Organization (PAHO) issued an alert regarding the first confirmed Zika virus infections in Brazil. The emergence of Zika virus in South America led to a rapid spread throughout South and Central America, reaching French Guiana in December 2015. With the increasing frequency of epidemics related to arbovirus and the resulting health, social, and economic impacts of dengue, the surveillance of arbovirus have become social, political, and public health challenges that require specific and non-available immune status information.

Full description

French Guiana is a 250,000 inhabitant's French overseas department located in South America, the epidemiology of arboviruses has recently evolved and marked by important outbreaks.

Dengue remains an important public health problem despite the efforts of local health authorities to mitigate the impact of epidemics and the epidemiology of dengue evolved from an endemo-epidemic to a hyper-endemic state. In late 2013, the first local transmission of chikungunya virus in the Americas was identified in Caribbean countries and territories including French Guiana. Rapidly, more than 16,000 suspected local Health authorities had reported cases. In May 2015, the Pan American Health Organization (PAHO) issued an alert regarding the first confirmed Zika virus infections in Brazil. The emergence of Zika virus in South America led to a rapid spread throughout South and Central America, reaching French Guiana in December 2015. With the increasing frequency of epidemics related to arbovirus and the resulting health, social, and economic impacts of dengue, the surveillance of arbovirus have become social, political, and public health challenges that require specific and non-available immune status information.

Enrollment: 2,697 patients

Sex: All

Ages: 2 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Guiana resident for at least 6 months and present during the entire study period
• Age between 2 and 75 years old

Exclusion criteria

• Subject under guardianship or deprived of liberty by judicial decision
• Subject with any pathology or health problem not compatible with blood sampling

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

2,697 participants in 1 patient group

Guiana population

Experimental group

Description:

Human Biological samples from Guiana population : Two serum tubes of blood will be collected

Treatment:

Other: Human Biological samples